Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
YWHAQ pseudogene 1 (YWHAQP1) is classified as a pseudogene, meaning it closely resembles the functional YWHAQ gene but does not encode a functional protein product[10][6]. The functional YWHAQ gene encodes the 14-3-3 protein theta, which is involved in signal transduction, cell cycle regulation, and apoptosis, with implications in diseases such as sporadic amyotrophic lateral sclerosis and Alzheimer’s disease[1][4][5][7]. However, YWHAQP1 itself is non-coding and does not serve as a molecular or pharmacological target[10]. No biological, clinical, or pharmacological attributes are attributed to this pseudogene in the literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on YWHAQ pseudogene 1 (YWHAQP1).